Hitto Kaufmann | Global Vice President of Biopharmaceutics Development
Sanofi Aventis Deutschland Germany Gmbh

Hitto Kaufmann, Global Vice President of Biopharmaceutics Development, Sanofi Aventis Deutschland Germany Gmbh

Dr Kaufmann is currently the Global Vice President of Biopharmaceutical Development and Platform Innovation within Sanofi, and has previously held the role of Vice President Process Science Germany within the global biopharmaceutical division of Boehringer Ingelheim. Before this Dr. Kaufmann was responsible for upstream development at the Biberach site as Director Upstream Development in 2008 and from 2010 onwards, as a Global Head of Mammalian Cell Culture Processes. He joined Boehringer Ingelheim in 2003 as Associate Director Cell Biology. Dr. Hitto Kaufmann also worked as a research scientist at the Walter and Eliza Hall Institute in Melbourne, Australia, identifying novel drug targets involved in apoptosis. He received his doctorate from the ETH Zürich working on improved production processes in CHO cells. Dr. Kaufmann is Member of several national and international committees and working groups, including the ESACT executive committee. He is co-inventor of more than 100 active intellectual property rights and served as editor of the Journal of Biotechnology between 2005 and 2010.


Advanced Therapies and Regenerative Medicine Day 2 - Thursday 17th May 2018 @ 12:00

Converging technologies driving innovation in Biomanufacturing

  • Further integration of upstream, downstream, formulation development and analytics
  • Increasing the understanding on how the process defines the product
  • Process intensification will be key

back to speakers

World Advanced Therapies & Regenerative Medicine Congress


Erica Baeta
+44 (0)207 092 1152


Jessica Robinson
t/ +44 (0)207 092 1150


Issa Mauthoor
+44 (0)207 092 1257